Kuijpens J L P, Verheij C D G W, Haak H R, Ribot J G, Hoekstra O S, Coebergh J W W
Integraal Kankercentrum Zuid, Postbus 231, 5600 AE Eindhoven.
Ned Tijdschr Geneeskd. 2004 Sep 11;148(37):1835-6.
In a previous study using data from the regional cancer registry of the Comprehensive Cancer Centre South, Eindhoven, The Netherlands, we concluded that in the majority of cases surgical treatment was in accordance with the consensus recommendations, but that about 40% of patients with differentiated thyroid cancer from a number of regional hospitals had not been referred for 131I therapy. However, in a subsequent study using patient data from these hospitals, it became clear that almost all patients had in fact been referred for therapy but to centres outside the 131I therapy region. The conclusion of the study should therefore be altered: the great majority of patients with differentiated thyroid cancer in the south-east of The Netherlands (1983-96) were referred for 131I treatment and therefore the primary surgical and the follow-up treatment complied with the 1987 consensus guidelines.
在之前一项使用荷兰埃因霍温市南部综合癌症中心区域癌症登记处数据的研究中,我们得出结论:在大多数情况下,手术治疗符合共识建议,但来自一些地区医院的约40%分化型甲状腺癌患者未被转诊接受¹³¹I治疗。然而,在随后一项使用这些医院患者数据的研究中,很明显几乎所有患者实际上都已被转诊接受治疗,但转诊到了¹³¹I治疗区域之外的中心。因此,该研究的结论应予以更改:荷兰东南部(1983 - 1996年)绝大多数分化型甲状腺癌患者被转诊接受¹³¹I治疗,因此初次手术和后续治疗符合1987年的共识指南。